uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
The flame-retardant BDE-99 dose-dependently affects viral replication in CVB3-infected mice
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Infectious Diseases.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Microbiology and Infectious Medicine.
2013 (English)In: Chemosphere, ISSN 0045-6535, E-ISSN 1879-1298, Vol. 91, no 10, 1434-1438 p.Article in journal (Refereed) Published
Abstract [en]

The flame retardant component 2,2',4,4',5-penta-BDE (BDE-99) is found in the environment and in human tissues and fluids. In mice the common human coxsackievirus B3 (CVB3) infection has been shown to change the tissue distribution of BDE-99. We now investigate how CVB3 infection in mice affects liver uptake of C-14 at two doses of radiolabelled BDE-99, and whether increased tissue levels are related to changed virus replication and gene expression of the proinflammatory chemokine monocyte chemoattractant protein-1 (MCP-1). Mice were infected on day 0, orally treated either with 200 mu g or 20 mg C-14-BDE-99/kg bw on day 1, and euthanised on day 3. Serum and liver levels of C-14-BDE-99, as well as virus levels and gene expressions of MCP-1 in the liver, were measured. In non-infected mice, there was a dose-dependent uptake of BDE-99 in both liver and serum, and in infected animals the liver BDE-99 levels was further increased. When comparing infected mice exposed to the two BDE-99 doses, the higher BDE dose resulted in increased virus amounts in the liver, and decreased infection-induced expression of MCP-1. Consequently, a high enough dose/tissue concentration of BDE-99 may result in a disturbed mobilisation of immune cells into infected tissues that could explain higher virus titres and a possibly altered clinical course of the disease. Moreover, the fact that CVB3 infection increased the BDE-99 levels in liver but not in serum may impair the risk assessment of polybrominated diphenyl ethers (PBDEs) in subclinical and clinically infected individuals, as serum levels is the common marker of exposure. 

Place, publisher, year, edition, pages
2013. Vol. 91, no 10, 1434-1438 p.
Keyword [en]
PBDE, Coxsackievirus B3, Tissue distribution, Virus levels, MCP-1
National Category
Natural Sciences Medical and Health Sciences
URN: urn:nbn:se:uu:diva-202897DOI: 10.1016/j.chemosphere.2013.01.044ISI: 000319094200008OAI: oai:DiVA.org:uu-202897DiVA: diva2:634644
Available from: 2013-07-01 Created: 2013-07-01 Last updated: 2013-07-01Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Ilbäck, Nils-Gunnar
By organisation
Infectious DiseasesClinical Microbiology and Infectious Medicine
In the same journal
Natural SciencesMedical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 143 hits
ReferencesLink to record
Permanent link

Direct link